Samaritan Pharmaceuticals, Inc. (SPHC.OB) Anticipates Continued Growth in 2008
Samaritan Pharmaceuticals, Inc. (SPHC.OB), a leading biopharmaceutical company, announced that corporate management have proven their ability to successfully lead the company when faced with the daunting task of commercializing breakthrough drugs. As a result, Samaritan's 2008 outlook is projected to be stronger then that witnessed during previous years. During the year 2007, Samaritan remained focused on developing and commercializing innovative therapeutic drugs. The Company made considerable progress when advancing their late stage HIV drug through two Phase II clinical trials; in addition to advancing their memory restoring Alzheimer's drug. Samaritan has also made considerable progress when further developing their new…